跳至主要内容
临床试验/IRCT20100126003181N2
IRCT20100126003181N2招募中3 期

The Effect of Riluzole on Tinnitus in Patients Referring to Amir Alam Hospital during 2017-18: A randomized, placebo-controlled clinical trial

Vice-chancellor for research,Tehran University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Having a chief complaint of tinnitus
  • Aged between 18-70
  • Tinnitus More than 3 months

排除标准

  • Middle and external ear disease
  • Patients with conductive and mixed hearing loss
  • The presence of the Pulsatile tinnitus type
  • The presence of temporomandibular joint disorders
  • Receiving medications with Systemic effects (in relation to tinnitus) over the past 6 months
  • The presence of tinnitus with a period Less than three months
  • Mild tinnitus (about THI <36)
  • Patients with liver and renal failure

研究者

发起方
Vice-chancellor for research,Tehran University of Medical Sciences

相似试验

Study of the effect of Riluzole on tinnitus... | 临床试验